Roche, Lead Pharma partner to develop oral small molecules for immune-mediated diseases

Roche, Lead Pharma partner to develop oral small molecules for immune-mediated diseases

Source: 
Pharmaceutical Business Review
snippet: 

Lead Pharma has signed a collaboration and license agreement with Roche for the development of oral small molecules to treat a range of immune-mediated diseases.